Enhancer RNAs: a missing regulatory layer in gene transcription.


Journal

Science China. Life sciences
ISSN: 1869-1889
Titre abrégé: Sci China Life Sci
Pays: China
ID NLM: 101529880

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 10 07 2018
accepted: 01 09 2018
pubmed: 30 12 2018
medline: 25 4 2020
entrez: 30 12 2018
Statut: ppublish

Résumé

Enhancers and super-enhancers exert indispensable roles in maintaining cell identity through spatiotemporally regulating gene transcription. Meanwhile, active enhancers and super-enhancers also produce transcripts termed enhancer RNAs (eRNAs) from their DNA elements. Although enhancers have been identified for more than 30 years, widespread transcription from enhancers are just discovered by genome-wide sequencing and considered as the key to understand longstanding questions in gene transcription. RNA-transcribed enhancers are marked by histone modifications such as H3K4m1/2 and H3K27Ac, and enriched with transcription regulatory factors such as LDTFs, P300, CBP, BRD4 and MED1. Those regulatory factors might constitute a Mega-Trans-like complex to potently activate enhancers. Compared to mRNAs, eRNAs are quite unstable and play roles at local. Functionally, it has been shown that eRNAs promote formation of enhancer-promoter loops. Several studies also demonstrated that eRNAs help the binding of RNA polymerase II (RNAPII) or transition of paused RNAPII by de-association of the negative elongation factor (NELF) complex. Nevertheless, these proposed mechanisms are not universally accepted and still under controversy. Here, we comprehensively summarize the reported findings and make perspectives for future exploration. We also believe that super-enhancer derived RNAs (seRNAs) might be informative to understand the nature of super-enhancers.

Identifiants

pubmed: 30593613
doi: 10.1007/s11427-017-9370-9
pii: 10.1007/s11427-017-9370-9
doi:

Substances chimiques

BRD4 protein, human 0
Cell Cycle Proteins 0
Histones 0
MED1 protein, human 0
Mediator Complex Subunit 1 0
RNA, Messenger 0
Transcription Factors 0
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-912

Auteurs

Renfang Mao (R)

Department of Pathophysiology, School of Medicine, Nantong University, Nantong, 226019, China.

Yuanyuan Wu (Y)

Basic Medical Research Center, School of Medicine, Nantong University, Nantong, 226019, China.

Yue Ming (Y)

Department of Immunology, School of Medicine, Nantong University, Nantong, 226019, China.

Yuanpei Xu (Y)

Department of Immunology, School of Medicine, Nantong University, Nantong, 226019, China.

Shouyan Wang (S)

Basic Medical Research Center, School of Medicine, Nantong University, Nantong, 226019, China.

Xia Chen (X)

Basic Medical Research Center, School of Medicine, Nantong University, Nantong, 226019, China.

Xiaoying Wang (X)

Department of Immunology, School of Medicine, Nantong University, Nantong, 226019, China.

Yihui Fan (Y)

Basic Medical Research Center, School of Medicine, Nantong University, Nantong, 226019, China. fanyihui@ntu.edu.cn.
Department of Immunology, School of Medicine, Nantong University, Nantong, 226019, China. fanyihui@ntu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH